OUTLINE:~Patients are randomized to 1 of 2 groups and their engagement in end-of-life planning is assessed at baseline and four weeks post-randomization.~Group I (intervention): Patients receive Peacefully's web-based tool to help with end-of-life planning on day 7.~Group II (control): Patients receive standard of care.~After completion of study, patients are followed up at 4, 12, and 24 weeks post-randomization.
This clinical trial examines a web-based tool, in partnership with Peacefully, Inc, designed to improve end-of-life planning among patients with advanced cancers. This program helps users prepare comprehensively for end-of-life (e.g., medical wishes, legal estate planning, financial planning and transfer of accounts, legacy building, and emotional support). It is expected that this web-based end-of-life planning program may reduce distress and improve end-of-life preparation among advanced cancer patients.